Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-09

DGX vs RDNT: stock comparison and AI forecast

Quest Diagnostics Inc (DGX) and Radnet, Inc. (RDNT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
NYSE · Services-Medical Laboratories

DGX Quest Diagnostics Inc

Price
$255.63 +34.7% · 6M
Market Cap
$28.12B
P/E Ratio
25.5x
Size
large-cap
AI Forecast
Full analysis →
Nasdaq · Services-Medical Laboratories

RDNT Radnet, Inc.

Price
$76.00 +36.0% · 6M
Market Cap
$5.98B
P/E Ratio
–
Size
mid-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-11 → 2026-11-09

Six-month price performance

Closing prices rebased to 100 at the start of the window.

100110120130140
DGX +34.7% RDNT +36.0%
DGX · RDNT

Key facts

  • DGX is 4.7 times larger than RDNT by market capitalization ($28.12B against $5.98B).
  • Over the last six months RDNT returned +36.0% and DGX +34.7%.
  • DGX turns 8064.3% of its revenue into net income, against -0.9% for RDNT.
  • RDNT carries 2.58 times debt per unit of equity, against 1.21 times for DGX.
  • DGX yields 1.31% in dividends; RDNT pays none.
  • Both companies share the SEC industry classification Services-Medical Laboratories.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricDGXRDNT
Market Cap$28.12B$5.98B
P/E Ratio25.46x–
P/B Ratio3.69x5.46x
Dividend Yield1.31%–
EPS$10.04$-0.34
Book Value/Share$69.37$13.93
Revenue/Share$0.13$28.83
FCF/Share$12.50–

Profitability & Margins

MetricDGXRDNT
ROE14.8%-1.9%
ROA6.6%-0.5%
ROIC11.2%2.0%
Gross Margin-56457.1%–
Operating Margin12307.1%3.1%
Net Margin8064.3%-0.9%
EBT Margin10871.4%1.5%
Tax Rate22.5%44.9%

Financial Health

MetricDGXRDNT
Current Ratio1.70x1.48x
Quick Ratio1.58x–
D/E Ratio1.21x2.58x
Financial Leverage2.26x3.86x
Interest Coverage–2.2x
Working Capital$1.28B$338M

Cash Flow

MetricDGXRDNT
Operating Cash Flow$1.95B$310M
Free Cash Flow$1.38B–
Capital Spending-$576M–
OCF Growth YoY3.5%18.4%
FCF Growth YoY-1.3%–
FCF/Sales9821.4%–
CapEx/Sales4114.3%–

Operational Efficiency

MetricDGXRDNT
Asset Turnover0.00x0.54x
Receivables Turnover0.0x9.4x
Inventory Turnover36.3x–
Fixed Assets Turnover0.0x2.6x
Days Sales Outstanding44634 days39 days
Days Inventory10 days–
Payables Period76 days–
Cash Conversion Cycle44569 days–

Income Statement

MetricDGXRDNT
Total Revenue$14M$2.27B
Operating Income$1.72B$71M
Net Income$1.13B-$21M
SG&A Expense$2.06B–
Cost of Goods Sold$7.92B–

Dividend & Shareholder Information

MetricDGXRDNT
Dividends Per Share$3.35–
Payout Ratio33.4%–
Shares Outstanding110M79M
Net Income Growth16.5%–
EPS Growth17.8%-225.9%
FAQ

DGX vs RDNT: stock comparison and AI forecast

Which is bigger, DGX or RDNT?

DGX is 4.7 times larger than RDNT by market capitalization ($28.12B against $5.98B).

Which stock performed better over the last six months, DGX or RDNT?

Over the last six months RDNT returned +36.0% and DGX +34.7%.

Which one does Intratio's AI model rank higher, DGX or RDNT?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.